Most Recent
Zoetis can appeal Boehringer win over pig vaccine patents
US animal drug manufacturer Zoetis has been granted leave to appeal a ruling that invalidated three of its patents covering pig vaccines.
$46.5M settlement reached in G8 class action, teeing up first contingency fee payout
Australia’s largest childcare centre operator G8 Education has agreed to pay $46.5 million to settle a shareholder class action alleging the company failed to keep investors in the loop about factors affecting its 2017 financial performance, and the firm that ran the case is set to make $13 million after securing the first group costs order in Victoria.
Apple says Fortnite maker paid no commission on US$3.8B in V-Bucks sales
Hitting back at claims that its App Store stifles competition, Apple has told a trial that app developers have myriad ways of maximising profits without paying it a commission, noting Epic Games made US$3.8 billion from in-game currency V-Bucks in 2021.
BHP fights class action’s bid to augment group after pleading mistake
A five-year-old class action against BHP over the collapse of a Brazilian dam is seeking to amend the group definition following a judgment limiting the class size, but the mining company says it should not be punished for the applicant’s pleading mistake.
Former EY partner tries again to keep identity under lid in tax case
A former EY partner is trying again to keep their identity secret in proceedings brought by the Tax Office alleging they promoted tax exploitation schemes.
Judge rejects ASIC’s first case over unfair insurance contract terms
A judge has dismissed the corporate regulator’s first-ever case over unfair insurance contracts terms, finding it was not unfair for an insurer to require customers to notify it if anything changed about their home or its contents.
Hells Angels takes IP fight with Redbubble to High Court
Hells Angels has asked the High Court to reinstate an award of $78,000 for online marketplace Redbubble's infringement of its trade marks, after the Full Court found it was owed just $100 in nominal damages.
Sun Pharma challenges Abilify patent term extension
Indian generics company Sun Pharma has taken Otsuka Pharmaceutical to court, alleging an extension for the patent for an injectable form of the Japanese drug maker's blockbuster antipsychotic Abilify was wrongly granted and should be invalidated.
Google slams ‘opportunistic’ app store class actions
Google has criticised two competition class actions which piggyback on claims brought by Fornite developer Epic Games as "opportunistic", but counsel for the class actions told a court the suits on behalf of more than 15 million group members were in the public interest.
Subpoenas to identify group members in Mercedes-Benz class action ‘improper’: judge
A judge has set aside subpoenas in a class action against Mercedes-Benz over alleged emissions cheating seeking material to identify group members and clarify the composition of the class, finding they were not issued for a legitimate forensic purpose.